London, 24 December 2009 - EastPharma (EAST LI), a company active in the
manufacturing and marketing of branded generic and in-licensed pharmaceutical
products in Turkey and selected emerging markets, announces today, following
yesterday?s Annual General Meeting of EastPharma Ltd, the appointment of Beat
Schlagenhauf as an independent director of the Board of Directors of EastPharma,
and the retirement of Wolfgang Stoiber from the Board of Directors of
EastPharma, with immediate effect.
For further information, please contact:
EastPharma
Idil Bora - Investor Relations
Tel: + 90 (212) 6929326
[HUG#1367704]
